Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01759030
What this trial is testing

Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biocad 181
Not applicableUnknownNCT05167643
What this trial is testing

H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study

Who this might be right for
Advanced HR+ HER2 Negative Breast Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Large-scale testing (Phase 3)Study completedNCT05405725
What this trial is testing

Compare Biosimilar Denosumab With Prolia®

Who this might be right for
Postmenopausal Osteoporosis
Enzene Biosciences Ltd. 504
Not applicableStudy completedNCT01626547
What this trial is testing

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more
Hospira, now a wholly owned subsidiary of Pfizer 291
Not applicableUnknownNCT03470688
What this trial is testing

Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
Opal Rheumatology Ltd. 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Not applicableUnknownNCT05240859
What this trial is testing

Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Peking University People's Hospital 1,600
Large-scale testing (Phase 3)Study completedNCT04522167
What this trial is testing

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Bioeq GmbH 434
Early research (Phase 1)WithdrawnNCT03131700
What this trial is testing

Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator

Who this might be right for
Healthy
TRPHARM
Early research (Phase 1)Not Yet RecruitingNCT07601620
What this trial is testing

Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer

Who this might be right for
HER2 + Breast Cancer
Shanghai Henlius Biotech 258
Testing effectiveness (Phase 2)Looking for participantsNCT05530057
What this trial is testing

Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer

Who this might be right for
Advanced Breast Cancer
Seoul National University Hospital 180
Not applicableLooking for participantsNCT06064864
What this trial is testing

Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD

Who this might be right for
Crohn's Disease
Asan Medical Center 100
Large-scale testing (Phase 3)Study completedNCT03425656
What this trial is testing

Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer

Who this might be right for
Malignant Neoplasm of Breast
AryoGen Pharmed Co. 108
Not applicableUnknownNCT05598684
What this trial is testing

SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Who this might be right for
Crohn DiseaseUlcerative ColitisRheumatoid Arthritis+2 more
Fresenius Kabi, France 600
Testing effectiveness (Phase 2)UnknownNCT06370065
What this trial is testing

Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Advanced Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Large-scale testing (Phase 3)Study completedNCT07146360
What this trial is testing

Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction

Who this might be right for
Myocardial Infarction (MI)
AO GENERIUM 180
Large-scale testing (Phase 3)Study completedNCT04930042
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Alvotech Swiss AG 581
Large-scale testing (Phase 3)UnknownNCT05771155
What this trial is testing

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®

Who this might be right for
Ulcerative Colitis
Polpharma Biologics S.A. 750
Early research (Phase 1)Ended earlyNCT03061838
What this trial is testing

Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera®

Who this might be right for
Rheumatoid Arthritis
Biointegrator LLC 8
Early research (Phase 1)Study completedNCT06481215
What this trial is testing

A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers

Who this might be right for
Healthy Volunteers
AO GENERIUM 122
Next Page